本期内容提示:
1、此前推的逆向并购概念股$Aerpio制药(ARPO)$ 宣布了并购,后续是否还有行情?哪些标的还有类似的潜力?
2、又一双抗药物平台获得多家机构建仓,是否有投资机会?
3、$Seelos Therapeutics(SEEL)$ 数据不错,缘何大跌,是否有抄底机会...查看全文
Seelos Therapeutics盘前跌4.25%,报0.153美元。消息上,在Seelos Therapeutics公布了SLS-002治疗抑郁症的2期临床试验数据后,Cantor Fitzgerald将该公司的评级从“增持”下调至“中性”,同时没有... 网页链接
$Seelos Therapeutics(SEEL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001136261-20-000180 Act: 34 Size: 3 MB 网页链接
$Seelos Therapeutics(SEEL)$ CT ORDER Confidential treatment order Accession Number: 9999999997-20-004692 Act: 33 Size: 905 KB 网页链接
$Seelos Therapeutics(SEEL)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001017491-20-000001 Act: 33 Size: 11 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001136261-20-000167 Act: 34 Size: 464 KB 网页链接
$Seelos Therapeutics(SEEL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001136261-20-000162 Act: 33 Size: 387 KB 网页链接
$Seelos Therapeutics(SEEL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001136261-20-000156 Act: 34 Size: 3 MB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-20-000138 Size: 5 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, item 8.01 Accession Number: 0001136261-20-000137 Act: 34 Size: 10 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001136261-20-000135 Act: 33 Size: 171 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K/A [Amend] Current report, items 3.03, 5.03, 5.07, and 9.01 Accession Number: 0001136261-20-000131 Act: 34 Size: 50 KB 网页链接